Webinar series: Reduction of alcohol consumption and cancer prevention

Webinar Series from WHO Europe on Alcohol and Cancer

On 27 May 2025, WHO Europe and IARC launched a series of four webinars to explore the link between alcohol consumption and cancer development. The sessions cover the latest scientific evidence and present key national prevention policies.

 

Alcohol consumption remains a major public health concern, in part due to its well-established role in increasing cancer risk. The International Agency for Research on Cancer (IARC) classifies alcoholic beverages as Group 1 carcinogens, based on sufficient evidence that alcohol causes cancers of the oral cavity, pharynx, larynx, esophagus, liver, colorectum and female breast in humans.

The program includes four dates: 27 May, 18 June, 3 September, and 24 September 2025. Topics include alcohol availability regulation, taxation, advertising restrictions, and risk communication.

The webinar series is primarily aimed at policy-makers; public health professionals; prevention specialists; health-care providers; representatives of civil society organizations; youth advocates; researchers, including early career researchers; and academics.

 

Upcomming Webinar schedule

 

Webinar 3: Availability policies – regulating access to reduce consumption
3 September 2025, 10:00–11:00 CEST

 

Webinar 4: Marketing bans – the role of advertising in alcohol consumption
24 September 2025, 15:00–16:00 CEST

 

Read more:
https://www.who.int/europe/news-room/events/item/2025/05/27/default-calendar/webinar-series–reduction-of-alcohol-consumption-and-cancer-prevention–what-can-we-learn-from-the-new-handbooks-from-the-international-agency-for-research-on-cancer

🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU tr

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Μετάβαση στο περιεχόμενο